Cure Diseases By Gene Programming™
The Genetic Code Of Life
We Are Committed To Making A Difference
For Sickle Cell And Thalassemia Patients
AkiraBio is a clinical-stage company pioneering molecularly targeted precision Gene Programming™ that Turns ON or OFF genes at DNA level to treat diseases at their source.
is built on the Precision Genetic Medicine potential of our lead product candidate, AB1, a highly selective, potent small molecule, hemoglobin inducer. AB1 is an oral, potentially disease-modifying treatment for rare hemoglobinopathies.